Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Translocase of outer mitochondrial membrane 20 (TOMM20) is a key receptor subunit of the translocase of the outer mitochondrial membrane (TOM complex), which facilitates the import of nuclear-encoded proteins into mitochondria[1][3]. TOMM20 specifically recognizes the N-terminal mitochondrial targeting sequences of precursor proteins and helps direct them to the mitochondrial matrix for further processing and function. Dysregulation or elevated expression of TOMM20 has been associated with several diseases, especially cancers such as thyroid cancer, and it is considered a crucial component for mitochondrial health and cellular energy metabolism[1][3][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Translocase of outer mitochondrial membrane 20 (TOMM20).